A Comparison of Two Expandable Metal Stents for the Palliation of Malignant Esophageal Disease
Recruiting
- Conditions
- 10017991malignant esophageal stenosis / esophageal narrowing and malignant esophageal fistulas
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Patients, 18 years of age and older, referred for stent placement for malignant esophageal disease
Exclusion Criteria
Location of lesions at less than 4 cm from upper gastro-intestinal sphincter.
Lesions longer than 9 cm. Patients who are unable to undergo endoscopy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>• To compare the reintervention rate</p><br>
- Secondary Outcome Measures
Name Time Method <p>• To compare the procedural failure rate.<br /><br>• To compare the early functional failure rate.<br /><br>• To compare the procedure related complications.<br /><br>• To compare the recurrence rate of dysphagia / esophageal leakage<br /><br>• To compare the survival rate. </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence stent patency in malignant esophageal stenosis with STEMA trial stents?
How do self-expanding metal stents compare to standard-of-care therapies for esophageal fistula palliation?
Which biomarkers predict response to covered vs. uncovered stents in esophageal cancer patients?
What are the management strategies for stent-related complications like tumor ingrowth in STEMA trial participants?
What competitor stent designs show improved outcomes for malignant esophageal disease compared to NL-OMON33264?